EDTA

Miami-Dade County Recognized as 2024 North American E-Visionary at EVS37 in Seoul, South Korea

Retrieved on: 
Thursday, April 25, 2024

Seoul, South Korea, April 25, 2024 (GLOBE NEWSWIRE) -- The Electric Drive Transportation Association (EDTA) recognized Miami-Dade County, Florida, as the 2024 North American E-Visionary at the 37th Electric Vehicle Symposium & Exhibition (EVS37) , currently underway in Seoul, South Korea.

Key Points: 
  • Seoul, South Korea, April 25, 2024 (GLOBE NEWSWIRE) -- The Electric Drive Transportation Association (EDTA) recognized Miami-Dade County, Florida, as the 2024 North American E-Visionary at the 37th Electric Vehicle Symposium & Exhibition (EVS37) , currently underway in Seoul, South Korea.
  • The E-Visionary Award honors cities and regions worldwide that are advancing electrification and working to realize the benefits of electric mobility in their communities.
  • As the North American representative to the World Electric Vehicle Association (WEVA) , EDTA is a partner in the organization’s Electric Vehicle Symposium (EVS) series, the longest-running international conference focused on electric transportation and technologies.
  • Earning this global recognition for our commitment to advancing electric vehicle transportation, equity, and sustainability is a true honor.

Antech’s breakthrough cancer screening tool launches in Europe, supporting early canine cancer detection

Retrieved on: 
Tuesday, April 23, 2024

A rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs, Nu.Q® testing also includes prevalent types of canine cancers, enabling veterinarians and pet owners to make informed decisions about cancer care more quickly.

Key Points: 
  • A rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs, Nu.Q® testing also includes prevalent types of canine cancers, enabling veterinarians and pet owners to make informed decisions about cancer care more quickly.
  • Jimmy Barr, DVM, DACVECC, Chief Medical Officer at Antech, part of Mars Science & Diagnostics said: “It’s exciting to see innovations like Nu.Q® Canine Cancer Test become more widely available to veterinary teams in Europe.
  • This is what our work at Antech is all about.”
    Nu.Q® Canine Cancer Test is a breakthrough technology that measures circulating nucleosomes, supporting earlier cancer detection in some of the most prevalent types of canine cancers.
  • ECVS, Tierklink Düsseldorf , used Nu.Q® Canine Cancer Test first-hand during the pilot phase and commented: “At our clinic, we see around 1500 cases of cancer in dogs a year.

Antech’s Breakthrough AI-powered Radiology and Targeted Cancer Screening Tools Now Available, Unleashing New Chapter for Veterinary Diagnostics

Retrieved on: 
Friday, April 12, 2024

Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the availability of two new breakthrough innovations to mark a new chapter for veterinary diagnostics.

Key Points: 
  • Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the availability of two new breakthrough innovations to mark a new chapter for veterinary diagnostics.
  • The webinar will be offered May 21 and 22, and veterinary professionals can sign up here on Antech’s website.
  • Also now available is Nu.Q® Canine Cancer Test, a rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs.
  • Nu.Q® cancer detection includes prevalent types of canine cancers enabling veterinarians and pet owners to make informed decisions about cancer care more quickly.

EDTA Board of Directors Announces New Leadership and Welcomes Walmart as a Member

Retrieved on: 
Wednesday, March 13, 2024

Washington, DC, March 13, 2024 (GLOBE NEWSWIRE) -- The Electric Drive Transportation Association (EDTA) elected a new Chair and Treasurer at its quarterly Board of Directors meeting in Washington, DC.

Key Points: 
  • Washington, DC, March 13, 2024 (GLOBE NEWSWIRE) -- The Electric Drive Transportation Association (EDTA) elected a new Chair and Treasurer at its quarterly Board of Directors meeting in Washington, DC.
  • Andre Welch, Director of Government Relations at Ford Motor Company, was elected Chair.
  • Christopher Hess, Vice President of Global Public Affairs at Eaton, was elected Treasurer.
  • The EDTA Board acknowledged their outstanding leadership and service to the association and its mission of advancing electric drive technologies and their benefits, including recent efforts to guide the implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Law.

Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test

Retrieved on: 
Friday, January 12, 2024

ORLANDO, Fla., Jan. 12, 2024 /PRNewswire/ -- Antech, the veterinary diagnostics company focused on helping veterinary professionals predict, diagnose and monitor wellness and disease, today announced it will launch the breakthrough in-hospital Nu.Q® Canine Cancer Test at this year's annual VMX meeting.

Key Points: 
  • ORLANDO, Fla., Jan. 12, 2024 /PRNewswire/ -- Antech, the veterinary diagnostics company focused on helping veterinary professionals predict, diagnose and monitor wellness and disease, today announced it will launch the breakthrough in-hospital Nu.Q® Canine Cancer Test at this year's annual VMX meeting.
  • Nu.Q ® is a breakthrough technology that measures circulating nucleosomes, supporting earlier cancer detection in some of the most prevalent types of canine cancers.
  • To learn more about the in-hospital Nu.Q ®, visit booth 1522 at VMX 2024 or speak to your local Antech representative.
  • The Nu.Q® Canine Cancer Test is supplied to Antech's Heska affiliate under license by Belgian Volition SRL.

Immunexpress Announces U.S. FDA Clearance of EDTA Blood Compatible Cartridges for SeptiCyte RAPID®

Retrieved on: 
Thursday, January 4, 2024

SEATTLE and BRISBANE, Australia, Jan. 4, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the clearance of EDTA blood compatible cartridges by the U.S. Food and Drug Administration (FDA) for use with SeptiCyte RAPID®. The updated SeptiCyte® RAPID cartridges add undiluted EDTA blood as a validated sample type within the U.S. healthcare market and have been available on the European market since August 2022.

Key Points: 
  • SEATTLE and BRISBANE, Australia, Jan. 4, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the clearance of EDTA blood compatible cartridges by the U.S. Food and Drug Administration (FDA) for use with SeptiCyte RAPID®.
  • The updated SeptiCyte® RAPID cartridges add undiluted EDTA blood as a validated sample type within the U.S. healthcare market and have been available on the European market since August 2022.
  • Their implementation allows for the use of standard EDTA blood collection tubes in place of proprietary PAXgene® blood RNA tubes.
  • BARDA awarded this grant to Immunexpress in 2020 as part of the DRIVe Solving Sepsis program.

Arqit Quantum Inc. Announces Financial and Operational Results for the Fiscal Year 2023

Retrieved on: 
Tuesday, November 21, 2023

LONDON, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (“Arqit”), a global leader in quantum-safe encryption, today announced its operational and financial results for the full fiscal year 30 September 2023.

Key Points: 
  • Arqit WalletSecure™ will be offered as part of an existing product offering of a major global financial services company.
  • During the second half of fiscal year 2023, Arqit delivered on revenue contracts with six channel partners representing sales of QuantumCloud™ Private Instance, QuantumCloud™ PaaS, Arqit NetworkSecure™ and Arqit TradeSecure™.
  • For the fiscal year ending 30 September 2023, Arqit issued 7,814,459 shares under the ATM Program, generating gross proceeds of $11.5 million.
  • Following the cost reduction initiative implemented in May 2023, Arqit’s headcount was 147 as of fiscal year end 2023.

Agricultural Micronutrients Market worth $6.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 8, 2023

Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.

Key Points: 
  • Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.
  • By mode of application, the fertigation segment is anticipated to grow at a significant rate in the agricultural micronutrients market.
  • Fertigation, the practice of applying micronutrients through irrigation systems, is gaining momentum in the agricultural micronutrients market due to several factors fastening its growth.
  • The cereal and grain crop type is anticipated to grow at a significant CAGR in the global agricultural micronutrients market.

Agricultural Micronutrients Market worth $6.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 8, 2023

Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.

Key Points: 
  • Boron, as an essential micronutrient in the agricultural micronutrients market, is experiencing rapid growth due to various influential factors.
  • By mode of application, the fertigation segment is anticipated to grow at a significant rate in the agricultural micronutrients market.
  • Fertigation, the practice of applying micronutrients through irrigation systems, is gaining momentum in the agricultural micronutrients market due to several factors fastening its growth.
  • The cereal and grain crop type is anticipated to grow at a significant CAGR in the global agricultural micronutrients market.

Secro, the new-generation e-bill of lading, achieves further legal and technical reliability certification

Retrieved on: 
Friday, November 3, 2023

Today, companies and banks willing to expedite and de-risk their transactions with e-bills of lading can do it with stronger certainty of legal recognition in front of courts and arbitrators.

Key Points: 
  • Today, companies and banks willing to expedite and de-risk their transactions with e-bills of lading can do it with stronger certainty of legal recognition in front of courts and arbitrators.
  • The first is its legal validity under both the Singapore Electronic Transaction Act and the more recent English ETDA, which translates into high flexibility.
  • The second is its technical and legal reliability even without the use of cumbersome, multiparty agreements.
  • To learn more about Secro please visit our website https://secro.io or contact [email protected] for a free trial of our platform.